{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:04:35Z","timestamp":1791813875474,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.toxicon.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T02:05:16Z","timestamp":1525658716000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Clinical studies of the effectiveness and safety of antivenoms"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-4632","authenticated-orcid":false,"given":"David J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrazaq G.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Warrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2018.05.001_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.toxicon.2009.10.024","article-title":"Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria","volume":"55","author":"Abubakar","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib2","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1371\/journal.pntd.0000767","article-title":"Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria","volume":"4","author":"Abubakar","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2018.05.001_bib3","article-title":"Antivenoms for snakebite envenoming: what is in the research pipeline?","volume":"10","author":"Alirol","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.toxicon.2018.05.001_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005612","article-title":"Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: evidence from a randomised controlled trial in Nepal","volume":"11","author":"Alirol","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2018.05.001_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4269\/ajtmh.1999.61.259","article-title":"A new monospecific ovine Fab fragment antivenom for treatment of envenoming by the Sri Lankan Russell's viper (Daboia russelii russelii): a preliminary dose-finding and pharmacokinetic study","volume":"61","author":"Ariaratnam","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0035-9203(01)90339-6","article-title":"An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii)","volume":"95","author":"Ariaratnam","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib7","series-title":"Sequential Medical Trials","author":"Armitage","year":"1975"},{"issue":"1","key":"10.1016\/j.toxicon.2018.05.001_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1678-9199-19-6","article-title":"Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa","volume":"19","author":"Bald\u00e9","year":"2013","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2018.05.001_bib9","series-title":"Envenomings and Their Treatments","article-title":"Serum therapy was discovered 100 years ago","author":"Bon","year":"1996"},{"key":"10.1016\/j.toxicon.2018.05.001_bib10","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1056\/NEJMoa0808455","article-title":"Antivenom for critically ill children with neurotoxicity from scorpion stings","volume":"360","author":"Boyer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2018.05.001_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxicon.2013.07.018","article-title":"Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms","volume":"74","author":"Boyer","year":"2013","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.toxicon.2018.05.001_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1258\/td.2010.100224","article-title":"Snake bites in Moyen Chari district, Chad: a five-year experience","volume":"41","author":"Bregani","year":"2011","journal-title":"Trop. Doct."},{"key":"10.1016\/j.toxicon.2018.05.001_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mem.2002.129939","article-title":"Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri)","volume":"40","author":"Bush","year":"2002","journal-title":"Ann. Emerg. Med."},{"issue":"1","key":"10.1016\/j.toxicon.2018.05.001_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/15563650.2014.974263","article-title":"Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial","volume":"53","author":"Bush","year":"2015","journal-title":"Clin. Toxicol. (Phila)."},{"key":"10.1016\/j.toxicon.2018.05.001_bib15","first-page":"160","article-title":"L'\u00e9tude experimentale du venin de Naja tripudians ou Cobra capel et expos\u00e9 d\u2019une m\u00e9thode de neutralisation de ce venin dans l\u2019organisme","volume":"6","author":"Calmette","year":"1892","journal-title":"Ann. L'institut Pasteur Locat."},{"key":"10.1016\/j.toxicon.2018.05.001_bib16","first-page":"275","article-title":"Contribution \u00e0 l'\u00e9tude du venin des serpents. Immunisation des animaux et traitement de l\u2019envenimation","volume":"8","author":"Calmette","year":"1894","journal-title":"Ann. L'institut Pasteur Locat."},{"key":"10.1016\/j.toxicon.2018.05.001_bib17","series-title":"Le venin des serpents Physiologie de le\u2019envenimation traitement des morsures venimeuses par le serum des animaux vaccin\u00e9s","author":"Calmette","year":"1896"},{"key":"10.1016\/j.toxicon.2018.05.001_bib18","series-title":"Les venions, les Animaux venimeux et la S\u00e9roth\u00e9rapie antivenimeuse","author":"Calmette","year":"1907"},{"key":"10.1016\/j.toxicon.2018.05.001_bib19","first-page":"315","article-title":"Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in S\u00e3o Paulo, Brazil","volume":"86","author":"Cardoso","year":"1993","journal-title":"Q. J. Med."},{"key":"10.1016\/j.toxicon.2018.05.001_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxicon.2014.11.223","article-title":"The lethality test used for estimating the potency of antivenoms against Bothrops asper snake venom: pathophysiological mechanisms, prophylactic analgesia, and a surrogate in vitro assay","volume":"93","author":"Chac\u00f3n","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib21","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.toxicon.2010.02.011","article-title":"The 3 + 3 dose escalation design is not appropriate for antivenom dose finding","volume":"55","author":"Chippaux","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib22","series-title":"Snake Venom Toxinology","first-page":"1","article-title":"Antivenom safety and tolerance for the strategy of snake envenomation management","author":"Chippaux","year":"2015"},{"issue":"8902","key":"10.1016\/j.toxicon.2018.05.001_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(94)90006-X","article-title":"Concorde: MRC\/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection","volume":"343","author":"Concorde Coordinating Committee","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2018.05.001_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/1740774514543538","article-title":"Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation","volume":"11","author":"Gerardo","year":"2014","journal-title":"Clin. Trials"},{"key":"10.1016\/j.toxicon.2018.05.001_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.annemergmed.2017.04.034","article-title":"The efficacy of crotalidae polyvalent immune Fab (ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled, clinical trial","volume":"70","author":"Gerardo","year":"2017","journal-title":"Ann. Emerg. Med."},{"issue":"5","key":"10.1016\/j.toxicon.2018.05.001_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9050163","article-title":"Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: state-of-the-art and challenges ahead","volume":"9","author":"Guti\u00e9rrez","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.toxicon.2018.05.001_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13181-010-0051-4","article-title":"A controlled clinical trial of a novel antivenom in patients envenomed by Bungarus multicinctus","volume":"6","author":"Ha","year":"2010","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.toxicon.2018.05.001_bib28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.toxicon.2010.02.013","article-title":"Response to a letter from J-P Chippaux and L Boyer entitled: \u2018\u2018The 3 + 3 dose escalation design is not appropriate for antivenom dose finding\u201d","volume":"55","author":"Habib","year":"2010","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.toxicon.2018.05.001_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.inhe.2010.08.001","article-title":"Factors affecting snakebite mortality in north-eastern Nigeria","volume":"3","author":"Habib","year":"2011","journal-title":"Int. Health"},{"key":"10.1016\/j.toxicon.2018.05.001_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxicon.2012.12.008","article-title":"On the use of analgesia in experimental toxinology","volume":"64","author":"Harris","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib31","doi-asserted-by":"crossref","first-page":"j5787","DOI":"10.1136\/bmj.j5787","article-title":"Is the concept of clinical equipoise still relevant to research?","volume":"359","author":"Hey","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.toxicon.2018.05.001_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-0101(86)90147-9","article-title":"A critical reappraisal of the use of enzyme-linked immunosorbent assays in the study of snake bite","volume":"24","author":"Ho","year":"1986","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.toxicon.2018.05.001_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038739","article-title":"A randomised controlled trial of two infusion rates to decrease reactions to antivenom","volume":"7","author":"Isbister","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2018.05.001_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0035-9203(95)90678-9","article-title":"A randomized 'blinded' comparison of two doses of antivenom in the treatment of Bothrops envenoming in Sao Paulo, Brazil","volume":"89","author":"Jorge","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib35","first-page":"235","article-title":"Report on snake venom","author":"Kanthack","year":"1895","journal-title":"Rep. Med. Off. L.G.B."},{"key":"10.1016\/j.toxicon.2018.05.001_bib36","series-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"2009"},{"issue":"6","key":"10.1016\/j.toxicon.2018.05.001_bib37","article-title":"Snake antivenom for snake venom induced consumption coagulopathy","volume":"9","author":"Maduwage","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.toxicon.2018.05.001_bib38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMra1510063","article-title":"Challenges in the design and interpretation of noninferiority trials","volume":"377","author":"Mauri","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.toxicon.2018.05.001_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.1997.56.291","article-title":"First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom","volume":"56","author":"Meyer","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cct.2013.09.003","article-title":"The ethics of placebo-controlled trials: methodological justifications","volume":"36","author":"Millum","year":"2013","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.toxicon.2018.05.001_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2017.04.015","article-title":"\u201cDry bite\u201d in venomous snakes: a review","volume":"133","author":"Naik","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4269\/ajtmh.1998.58.183","article-title":"A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER)","volume":"58","author":"Otero-Pati\u00f1o","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0041-0101(98)00220-7","article-title":"A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms","volume":"37","author":"Otero","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib44","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.trstmh.2006.01.006","article-title":"Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia","volume":"100","author":"Otero","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.toxicon.2018.05.001_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9050158","article-title":"Third generation antivenomics: pushing the limits of the in vitro preclinical assessment of antivenoms","volume":"9","author":"Pla","year":"2017","journal-title":"Toxins (Basel)."},{"issue":"8","key":"10.1016\/j.toxicon.2018.05.001_bib46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.toxicon.2008.09.002","article-title":"Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids","volume":"52","author":"Ramos-Cerrillo","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib47","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bmj.2.5369.1378","article-title":"Specific antivenene and prednisone in viper-bite poisoning: controlled trial","volume":"2","author":"Reid","year":"1963","journal-title":"Br. Med. J."},{"issue":"9","key":"10.1016\/j.toxicon.2018.05.001_bib48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.trstmh.2005.10.006","article-title":"A randomized, double-blind, placebo-controlled trial of antivenom for local effects of green pit viper bites","volume":"100","author":"Rojnuckarin","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib49","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/sim.1229","article-title":"Competing designs for phase I clinical trials: a review","volume":"21","author":"Rosenberger","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.toxicon.2018.05.001_bib50","series-title":"Venomous Animals and Their Venoms","first-page":"345","article-title":"Symptomatology, pathology, and treatment of snake bites in South America","volume":"vol. II","author":"Rosenfeld","year":"1972"},{"issue":"4","key":"10.1016\/j.toxicon.2018.05.001_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9040143","article-title":"Antivenom for neuromuscular paralysis resulting from snake envenoming","volume":"9","author":"Silva","year":"2017","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.toxicon.2018.05.001_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bmj.329.7475.1129","article-title":"Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms","volume":"329","author":"Smalligan","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.toxicon.2018.05.001_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0041-0101(83)90090-9","article-title":"The application of immunoassay techniques, including enzyme-linked immunosorbent assay (ELISA), to snake venom research","volume":"21","author":"Theakston","year":"1983","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2018.05.001_bib54","series-title":"Researches on Australian Venoms. Snake-bite, Snake-venom and Antivenine. The Poison of the Platypus. The Poison of the Red-spotted Spider","author":"Tidswell","year":"1906"},{"key":"10.1016\/j.toxicon.2018.05.001_bib55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0035-9203(79)90058-0","article-title":"Therapeutic trial of intracisternal human tetanus immunoglobulin in clinical tetanus","volume":"73","author":"Vakil","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2007.11.006","article-title":"Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance","volume":"102","author":"Visser","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.toxicon.2018.05.001_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4269\/ajtmh.1986.35.173","article-title":"ELISA confirmation of acute and past envenoming by the monocellate Thai cobra (Naja kaouthia)","volume":"35","author":"Viravan","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.trstmh.2007.12.005","article-title":"Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product--\u2018what's in a name?\u2019","volume":"102","author":"Warrell","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib59","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.trstmh.2009.06.004","article-title":"Response to comment on: failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance","volume":"103","author":"Warrell","year":"2009","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib60","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4269\/ajtmh.1986.35.1235","article-title":"Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations","volume":"35","author":"Warrell","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib61","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/bmj.4.5942.437","article-title":"Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms","volume":"4","author":"Warrell","year":"1974","journal-title":"Br. Med. J."},{"issue":"181","key":"10.1016\/j.toxicon.2018.05.001_bib62","first-page":"33","article-title":"Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria","volume":"46","author":"Warrell","year":"1977","journal-title":"Q. J. Med."},{"issue":"6214","key":"10.1016\/j.toxicon.2018.05.001_bib63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bmj.280.6214.607","article-title":"Comparison of Pasteur and Behringwerke antivenoms in envenoming by the carpet viper (Echis carinatus)","volume":"280","author":"Warrell","year":"1980","journal-title":"Br. Med. J."},{"key":"10.1016\/j.toxicon.2018.05.001_bib64","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0035-9203(89)90301-5","article-title":"Comparison of Tensilon and antivenom for the treatment of cobra-bite paralysis","volume":"83","author":"Watt","year":"1989","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2018.05.001_bib65","series-title":"Guidelines for the Production, Control and Regulation of Snake Antivenom Mmunoglobulins","author":"WHO","year":"2018"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010118301764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010118301764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:09:56Z","timestamp":1758575396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010118301764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":65,"alternative-id":["S0041010118301764"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2018.05.001","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical studies of the effectiveness and safety of antivenoms","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}